Author:
Yang Junbao,Jones Maris S.,Ramos Romela Irene,Chan Alfred A.,Lee Agnes F.,Foshag Leland J.,Sieling Peter A.,Faries Mark B.,Lee Delphine J.
Funder
National Institutes of Health
Reference69 articles.
1. Vital signs: melanoma incidence and mortality trends and projections – United States, 1982–2030;Guy;MMWR Morb Mortal Wkly Rep,2015
2. Nivolumab in melanoma: latest evidence and clinical potential;Johnson;Ther Adv Med Oncol,2015
3. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015
4. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011
5. Immunological factors which influence response to immunotherapy in malignant melanoma;Morton;Surgery,1970
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献